SE9601158D0 - Method of producing immunogenic products and vaccines - Google Patents

Method of producing immunogenic products and vaccines

Info

Publication number
SE9601158D0
SE9601158D0 SE9601158A SE9601158A SE9601158D0 SE 9601158 D0 SE9601158 D0 SE 9601158D0 SE 9601158 A SE9601158 A SE 9601158A SE 9601158 A SE9601158 A SE 9601158A SE 9601158 D0 SE9601158 D0 SE 9601158D0
Authority
SE
Sweden
Prior art keywords
pct
immunogenic product
sec
vaccines
date
Prior art date
Application number
SE9601158A
Other languages
English (en)
Swedish (sv)
Inventor
Stefan Svenson
Original Assignee
Stefan Svenson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stefan Svenson filed Critical Stefan Svenson
Priority to SE9601158A priority Critical patent/SE9601158D0/xx
Publication of SE9601158D0 publication Critical patent/SE9601158D0/xx
Priority to EP97908244A priority patent/EP0894008B1/en
Priority to AT97908244T priority patent/ATE218369T1/de
Priority to PCT/EP1997/001321 priority patent/WO1997035613A1/en
Priority to US09/147,045 priority patent/US6165468A/en
Priority to JP9533996A priority patent/JP2000507252A/ja
Priority to AU20277/97A priority patent/AU2027797A/en
Priority to DE69713089T priority patent/DE69713089T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9601158A 1996-03-25 1996-03-26 Method of producing immunogenic products and vaccines SE9601158D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9601158A SE9601158D0 (sv) 1996-03-26 1996-03-26 Method of producing immunogenic products and vaccines
EP97908244A EP0894008B1 (en) 1996-03-26 1997-03-17 Method of producing immunogenic products and vaccines
AT97908244T ATE218369T1 (de) 1996-03-26 1997-03-17 Verfahren zur herstellung von immunoaktiven mittel und impfstoffe
PCT/EP1997/001321 WO1997035613A1 (en) 1996-03-26 1997-03-17 Method of producing immunogenic products and vaccines
US09/147,045 US6165468A (en) 1996-03-25 1997-03-17 Antigenic carbohydrate linked to an immunogenic carrier
JP9533996A JP2000507252A (ja) 1996-03-26 1997-03-17 免疫性物質を産生する方法及びワクチン
AU20277/97A AU2027797A (en) 1996-03-26 1997-03-17 Method of producing immunogenic products and vaccines
DE69713089T DE69713089T2 (de) 1996-03-26 1997-03-17 Verfahren zur herstellung von immunoaktiven mittel und impfstoffe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601158A SE9601158D0 (sv) 1996-03-26 1996-03-26 Method of producing immunogenic products and vaccines

Publications (1)

Publication Number Publication Date
SE9601158D0 true SE9601158D0 (sv) 1996-03-26

Family

ID=20401951

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601158A SE9601158D0 (sv) 1996-03-25 1996-03-26 Method of producing immunogenic products and vaccines

Country Status (8)

Country Link
US (1) US6165468A (ja)
EP (1) EP0894008B1 (ja)
JP (1) JP2000507252A (ja)
AT (1) ATE218369T1 (ja)
AU (1) AU2027797A (ja)
DE (1) DE69713089T2 (ja)
SE (1) SE9601158D0 (ja)
WO (1) WO1997035613A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797275B1 (en) * 1998-12-04 2004-09-28 The United States Of America As Represented By The Department Of Health And Human Services Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
US6146902A (en) * 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
SE9900496D0 (sv) 1999-02-12 1999-02-12 Pharmatrix Ab Vaccine formulation
CA2363118A1 (en) * 1999-02-25 2000-08-31 Smithkline Beecham Biologicals S.A. Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
TR200102739T2 (tr) 1999-03-19 2001-12-21 Smithkline Beecham Biologicals S.A. Aşı
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
SI2283857T1 (sl) 2005-06-27 2019-11-29 Glaxosmithkline Biologicals Sa Sestava cepiva, ki obsega konjugirane nativne kapsularne polisaharide n. meningitidis
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0214995B1 (en) * 1985-03-04 1990-12-27 Dana Farber Cancer Institute Immunotoxin and method of making
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
IE62463B1 (en) * 1988-07-07 1995-02-08 Res Dev Foundation Immunoconjugates for cancer diagnosis and therapy
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5370872A (en) * 1991-08-12 1994-12-06 Swiss Serum And Vaccine Institute Berne Escherichia coliO-polysaccharide-protein conjugate vaccine
US5622929A (en) * 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines

Also Published As

Publication number Publication date
DE69713089T2 (de) 2003-01-02
DE69713089D1 (de) 2002-07-11
ATE218369T1 (de) 2002-06-15
WO1997035613A1 (en) 1997-10-02
JP2000507252A (ja) 2000-06-13
EP0894008A1 (en) 1999-02-03
US6165468A (en) 2000-12-26
EP0894008B1 (en) 2002-06-05
AU2027797A (en) 1997-10-17

Similar Documents

Publication Publication Date Title
TR199900848T2 (xx) Oksadiazoller, elde edilmeleri ve ila� olarak kullan�mlar�.
DE69317433T3 (de) Ungesättigte aliphatische dicarbonsäuren
ZA954641B (en) Polynucleotide vaccine for papilloma virus
SE9601158D0 (sv) Method of producing immunogenic products and vaccines
SE9300140D0 (sv) Solid substrate
DE59604230D1 (de) Alk(en)yldicarbonsäurebisester, deren verwendung sowie verfahren zu deren herstellung
TR199900501T2 (xx) Benzamin t�revleri ve bunlar�n ila� olarak kullan�m�.
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
FI971293A (fi) Menetelmä tärkkelyksen hajoamistuotteiden valmistamiseksi
SE9900496D0 (sv) Vaccine formulation
TW367326B (en) Pyrimidine derivative, process for the preparation thereof and a pharmaceutical composition containing same
ATE201882T1 (de) Formulierung von energie
PL322847A1 (en) Condensed b-carbolins